HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Free HPV shots help prevent cancer in Low-Income adults
⭐️ VACCINE ⭐️ CompletedThis study tested whether an education program helps low-income, uninsured adults aged 18-45 accept and complete a free HPV vaccine series. The goal is to prevent HPV-related cancers. About 100 participants took part, and researchers tracked how many started and finished the vacc…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
Engineered immune cells take on HPV cancers in early trial
Disease control CompletedThis study tested a new experimental treatment called HPVST cells in 32 people with HPV-related cancers that had returned or not responded to standard care. The cells are grown from the patient's own blood and trained to attack HPV-infected cancer cells. The goal was to find a sa…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a 3-Week radiation blast tame HPV throat cancer?
Disease control CompletedThis early-phase study tested a shorter, more intense radiation schedule (completed in 3 weeks instead of the usual 6) combined with chemotherapy for people with HPV-related throat cancer. The goal was to find the safest dose that still controls the cancer. Only 24 patients took …
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC